BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Frydecka D, Krzystek-Korpacka M, Lubeiro A, Stramecki F, Stańczykiewicz B, Beszłej JA, Piotrowski P, Kotowicz K, Szewczuk-Bogusławska M, Pawlak-Adamska E, Misiak B. Profiling inflammatory signatures of schizophrenia: A cross-sectional and meta-analysis study. Brain Behav Immun 2018;71:28-36. [PMID: 29730395 DOI: 10.1016/j.bbi.2018.05.002] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 18.0] [Reference Citation Analysis]
Number Citing Articles
1 Mednova IA, Boiko AS, Kornetova EG, Semke AV, Bokhan NA, Ivanova SA. Cytokines as Potential Biomarkers of Clinical Characteristics of Schizophrenia. Life 2022;12:1972. [DOI: 10.3390/life12121972] [Reference Citation Analysis]
2 Aichholzer M, Gangadin SS, Sommer IE, Wijkhuis A, de Witte LD, Kahn RS, Bahn S, Drexhage HA, Schiweck C. Inflammatory monocyte gene signature predicts beneficial within group effect of simvastatin in patients with schizophrenia spectrum disorders in a secondary analysis of a randomized controlled trial. Brain, Behavior, & Immunity - Health 2022. [DOI: 10.1016/j.bbih.2022.100551] [Reference Citation Analysis]
3 Trindade P, Nascimento JM, Casas BS, Monteverde T, Gasparotto J, Ribeiro CT, Devalle S, Sauma D, Moreira JCF, Gelain DP, Porciuncula LO, Palma V, Martins-de-souza D, Rehen SK. Induced pluripotent stem cell-derived astrocytes from patients with schizophrenia exhibit an inflammatory phenotype that affects vascularization. Mol Psychiatry 2022. [DOI: 10.1038/s41380-022-01830-1] [Reference Citation Analysis]
4 Elkjaer Greenwood Ormerod MB, Ueland T, Frogner Werner MC, Hjell G, Rødevand L, Sæther LS, Lunding SH, Johansen IT, Ueland T, Lagerberg TV, Melle I, Djurovic S, Andreassen OA, Steen NE. Composite immune marker scores associated with severe mental disorders and illness course. Brain, Behavior, & Immunity - Health 2022;24:100483. [DOI: 10.1016/j.bbih.2022.100483] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fitton R, Sweetman J, Heseltine-carp W, van der Feltz-cornelis C. Anti-inflammatory medications for the treatment of mental disorders: A scoping review. Brain, Behavior, & Immunity - Health 2022. [DOI: 10.1016/j.bbih.2022.100518] [Reference Citation Analysis]
6 Casas BS, Arancibia-altamirano D, Acevedo-la Rosa F, Garrido-jara D, Maksaev V, Pérez-monje D, Palma V. It takes two to tango: Widening our understanding of the onset of schizophrenia from a neuro-angiogenic perspective. Front Cell Dev Biol 2022;10:946706. [DOI: 10.3389/fcell.2022.946706] [Reference Citation Analysis]
7 de Bartolomeis A, Barone A, Vellucci L, Mazza B, Austin MC, Iasevoli F, Ciccarelli M. Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review. Mol Neurobiol 2022. [PMID: 35963926 DOI: 10.1007/s12035-022-02976-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Lestra V, Romeo B, Martelli C, Benyamina A, Hamdani N. Could CRP be a differential biomarker of illness stages in schizophrenia? A systematic review and meta-analysis. Schizophr Res 2022;246:175-86. [PMID: 35785580 DOI: 10.1016/j.schres.2022.06.026] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Foiselle M, Barbosa S, Godin O, Wu C, Boukouaci W, Andre M, Aouizerate B, Berna F, Barau C, Capdevielle D, Vidailhet P, Chereau I, Davidovic L, Dorey J, Dubertret C, Dubreucq J, Faget C, Fond G, Leigner S, Llorca P, Mallet J, Misdrahi D, Martinuzzi E, Passerieux C, Rey R, Pignon B, Urbach M, Schürhoff F, Glaichenhaus N, Leboyer M, Tamouza R, Berna F, Haffen E, Leboyer M, Llorca P, Schürhoff F, Barteau V, Bensalem S, Godin O, Laouamri H, Souryis K, Leboyer M, Offerlin-meyer I, Pignon B, Schürhoff F, Szöke A, Aouizerate B, Deloge A, Misdrahi D, Vilà E, Blanc O, Chéreau I, Denizot H, Honciuc R, Lacelle D, Llorca P, Pires S, Dubertret C, Mallet J, Portalier C, Dubreucq J, Fluttaz C, Gabayet F, Roman C, Chesnoy-servanin G, D'amato T, Dorey J, Rey R, Vehier A, Lançon C, Faget C, Metairie E, Peri P, Vaillant F, Boyer L, Fond G, Berna F, Vidailhet P, Zinetti-bertschy A, Capdevielle D, Yazbek H, Esselin S, Jarroir M, Passerieux C, Urbach M. Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohort. Brain, Behavior, & Immunity - Health 2022;22:100436. [DOI: 10.1016/j.bbih.2022.100436] [Reference Citation Analysis]
10 Coentre R, Levy P, Góis C, Figueira ML. Metabolic syndrome following a first episode of psychosis: results of a 1-year longitudinal study conducted in metropolitan Lisbon, Portugal. J Int Med Res 2022;50:3000605221106703. [PMID: 35726606 DOI: 10.1177/03000605221106703] [Reference Citation Analysis]
11 Ermakov EA, Melamud MM, Buneva VN, Ivanova SA. Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives. Front Psychiatry 2022;13:880568. [PMID: 35546942 DOI: 10.3389/fpsyt.2022.880568] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Saoud H, Ben Afia A, Aflouk Y, Gaha L, Bel Hadj Jrad B. A Preventive Role of RANTES Genetic Variation against Undifferentiated Schizophrenia. Immunol Invest 2022;:1-13. [PMID: 35476033 DOI: 10.1080/08820139.2022.2067001] [Reference Citation Analysis]
13 Cierpka A, Sternak A, Wasiak A, Siudem-kuna J, Walicka N. ‘Gypsum on water. That schizophrenia.’ schizophrenia – a meeting of stories: a qualitative study. Disability & Society. [DOI: 10.1080/09687599.2022.2061332] [Reference Citation Analysis]
14 Abrantes A, Giusti-Rodriguez P, Ancalade N, Sekle S, Basiri ML, Stuber GD, Sullivan PF, Hultman R. Gene expression changes following chronic antipsychotic exposure in single cells from mouse striatum. Mol Psychiatry 2022. [PMID: 35322200 DOI: 10.1038/s41380-022-01509-7] [Reference Citation Analysis]
15 Yan J, Chen Y, Ju P, Gao J, Zhang L, Li J, Wang K, Zhang J, Li C, Xia Q, Zhu C, Zhang X. Network Association of Biochemical and Inflammatory Abnormalities With Psychiatric Symptoms in First-Episode Schizophrenia Patients. Front Psychiatry 2022;13:834539. [PMID: 35273531 DOI: 10.3389/fpsyt.2022.834539] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Trindade P, Nascimento JM, Casas BS, Faúndez TM, Gasparotto J, Ribeiro CT, Devalle S, Sauma D, Moreira JCF, Gelain DP, Porciuncula LO, Palma V, Martins-de-souza D, Rehen SK. Induced pluripotent stem cell-derived astrocytes from patients with schizophrenia exhibit an inflammatory phenotype that affects vascularization.. [DOI: 10.1101/2022.03.07.483024] [Reference Citation Analysis]
17 Yilmaz Kafali H, Turan S, Akpınar S, Mutlu M, Özkaya Parlakay A, Çöp E, Toulopoulou T. Correlates of psychotic like experiences (PLEs) during Pandemic: An online study investigating a possible link between the SARS-CoV-2 infection and PLEs among adolescents. Schizophrenia Research 2022;241:36-43. [DOI: 10.1016/j.schres.2021.12.049] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Dunleavy C, Elsworthy RJ, Upthegrove R, Wood SJ, Aldred S. Inflammation in first-episode psychosis: The contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta-analysis. Acta Psychiatr Scand 2022. [PMID: 35202480 DOI: 10.1111/acps.13416] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
19 Lin P, Sun J, Lou X, Li D, Shi Y, Li Z, Ma P, Li P, Chen S, Jin W, Liu S, Chen Q, Gao Q, Zhu L, Xu J, Zhu M, Wang M, Liang K, Zhao L, Xu H, Dong K, Li Q, Cheng X, Chen J, Guo X. Consensus on potential biomarkers developed for use in clinical tests for schizophrenia. Gen Psych 2022;35:e100685. [DOI: 10.1136/gpsych-2021-100685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Zakowicz P, Pawlak J, Kapelski P, Wiłkość-Dębczyńska M, Szałkowska A, Twarowska-Hauser J, Rybakowski J, Skibińska M. Genetic association study reveals impact of interleukin 10 polymorphisms on cognitive functions in schizophrenia. Behav Brain Res 2022;419:113706. [PMID: 34875307 DOI: 10.1016/j.bbr.2021.113706] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Chen X, Yao T, Cai J, Fu X, Li H, Wu J. Systemic inflammatory regulators and 7 major psychiatric disorders: A two-sample Mendelian randomization study. Prog Neuropsychopharmacol Biol Psychiatry 2022;:110534. [PMID: 35150783 DOI: 10.1016/j.pnpbp.2022.110534] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Luís JP, Simões CJV, Brito RMM. The Therapeutic Prospects of Targeting IL-1R1 for the Modulation of Neuroinflammation in Central Nervous System Disorders. Int J Mol Sci 2022;23:1731. [PMID: 35163653 DOI: 10.3390/ijms23031731] [Reference Citation Analysis]
23 Michalczyk A, Tyburski E, Podwalski P, Waszczuk K, Rudkowski K, Kucharska-mazur J, Mak M, Rek-owodziń K, Plichta P, Bielecki M, Andrusewicz W, Cecerska-heryć E, Samochowiec A, Misiak B, Sagan L, Samochowiec J. Serum inflammatory markers and their associations with white matter integrity of the corpus callosum in schizophrenia patients and healthy controls. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2022. [DOI: 10.1016/j.pnpbp.2022.110510] [Reference Citation Analysis]
24 Chen L, Zheng WH, Du Y, Li XS, Yu Y, Wang H, Cheng Y. Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications. Front Med (Lausanne) 2021;8:757655. [PMID: 34901070 DOI: 10.3389/fmed.2021.757655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zhou D, Xie C, Li X, Song N, Kou Z, Zhang T, Yuan T. Rare presence of autoantibodies targeting to NMDA and GABAA receptors in schizophrenia patients. Schizophrenia Research 2021. [DOI: 10.1016/j.schres.2021.12.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Estevao C, Bowers CE, Luo D, Sarker M, Hoeh AE, Frudd K, Turowski P, Greenwood J. CCL4 induces inflammatory signalling and barrier disruption in the neurovascular endothelium. Brain Behav Immun Health 2021;18:100370. [PMID: 34755124 DOI: 10.1016/j.bbih.2021.100370] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
27 Chitu V, Biundo F, Stanley ER. Colony stimulating factors in the nervous system. Semin Immunol 2021;:101511. [PMID: 34743926 DOI: 10.1016/j.smim.2021.101511] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
28 Hazelgrove K. The role of the immune system in postpartum psychosis. Brain Behav Immun Health 2021;18:100359. [PMID: 34704078 DOI: 10.1016/j.bbih.2021.100359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Dawidowski B, Górniak A, Podwalski P, Lebiecka Z, Misiak B, Samochowiec J. The Role of Cytokines in the Pathogenesis of Schizophrenia. J Clin Med 2021;10:3849. [PMID: 34501305 DOI: 10.3390/jcm10173849] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
30 Klein-petersen AW, Köhler-forsberg O, Benros ME. Infections, antibiotic treatment and the Microbiome in relation to schizophrenia. Schizophrenia Research 2021;234:71-7. [DOI: 10.1016/j.schres.2019.11.033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
31 Perry BI, Upthegrove R, Kappelmann N, Jones PB, Burgess S, Khandaker GM. Associations of immunological proteins/traits with schizophrenia, major depression and bipolar disorder: A bi-directional two-sample mendelian randomization study. Brain Behav Immun 2021:S0889-1591(21)00273-7. [PMID: 34280516 DOI: 10.1016/j.bbi.2021.07.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 18.0] [Reference Citation Analysis]
32 Tanaka M, Tóth F, Polyák H, Szabó Á, Mándi Y, Vécsei L. Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway. Biomedicines 2021;9:734. [PMID: 34202246 DOI: 10.3390/biomedicines9070734] [Cited by in Crossref: 59] [Cited by in F6Publishing: 67] [Article Influence: 59.0] [Reference Citation Analysis]
33 Boczek T, Mackiewicz J, Sobolczyk M, Wawrzyniak J, Lisek M, Ferenc B, Guo F, Zylinska L. The Role of G Protein-Coupled Receptors (GPCRs) and Calcium Signaling in Schizophrenia. Focus on GPCRs Activated by Neurotransmitters and Chemokines. Cells 2021;10:1228. [PMID: 34067760 DOI: 10.3390/cells10051228] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
34 Melbourne JK, Rosen C, Chase KA, Feiner B, Sharma RP. Monocyte Transcriptional Profiling Highlights a Shift in Immune Signatures Over the Course of Illness in Schizophrenia. Front Psychiatry 2021;12:649494. [PMID: 34054608 DOI: 10.3389/fpsyt.2021.649494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Klaus F, Mitchell K, Liou SC, Eyler LT, Nguyen TT. Chemokine MCP1 is associated with cognitive flexibility in schizophrenia: A preliminary analysis. J Psychiatr Res 2021;138:139-45. [PMID: 33852994 DOI: 10.1016/j.jpsychires.2021.04.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
36 Römer C. Viruses and Endogenous Retroviruses as Roots for Neuroinflammation and Neurodegenerative Diseases. Front Neurosci 2021;15:648629. [PMID: 33776642 DOI: 10.3389/fnins.2021.648629] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
37 Enache D, Nikkheslat N, Fathalla D, Morgan BP, Lewis S, Drake R, Deakin B, Walters J, Lawrie SM, Egerton A, MacCabe JH, Mondelli V. Peripheral immune markers and antipsychotic non-response in psychosis. Schizophr Res 2021;230:1-8. [PMID: 33667853 DOI: 10.1016/j.schres.2020.12.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
38 Tsai S. Role of interleukin 8 in depression and other psychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2021;106:110173. [DOI: 10.1016/j.pnpbp.2020.110173] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 14.0] [Reference Citation Analysis]
39 Prestwood TR, Asgariroozbehani R, Wu S, Agarwal SM, Logan RW, Ballon JS, Hahn MK, Freyberg Z. Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia. Behav Brain Res 2021;402:113101. [PMID: 33453341 DOI: 10.1016/j.bbr.2020.113101] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
40 Pan X, Kaminga AC, Wu Wen S, Liu A. Chemokines in post-traumatic stress disorder: A network meta-analysis. Brain Behav Immun 2021;92:115-26. [PMID: 33242653 DOI: 10.1016/j.bbi.2020.11.033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
41 Du Y, Chen L, Li XS, Li XL, Xu XD, Tai SB, Yang GL, Tang Q, Liu H, Liu SH, Zhang SY, Cheng Y. Metabolomic Identification of Exosome-Derived Biomarkers for Schizophrenia: A Large Multicenter Study. Schizophr Bull 2021;47:615-23. [PMID: 33159208 DOI: 10.1093/schbul/sbaa166] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
42 Mazza MG, Capellazzi M, Lucchi S, Tagliabue I, Rossetti A, Clerici M. Monocyte count in schizophrenia and related disorders: a systematic review and meta-analysis. Acta Neuropsychiatr 2020;32:229-36. [PMID: 32178747 DOI: 10.1017/neu.2020.12] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
43 Ben Afia A, Aflouk Y, Saoud H, Zaafrane F, Gaha L, Bel Hadj Jrad B. Inteurleukin-8 gene variations and the susceptibility to schizophrenia. Psychiatry Res 2020;293:113421. [PMID: 32920525 DOI: 10.1016/j.psychres.2020.113421] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
44 Ivanovska M, Abdi Z, Murdjeva M, Macedo D, Maes A, Maes M. CCL-11 or Eotaxin-1: An Immune Marker for Ageing and Accelerated Ageing in Neuro-Psychiatric Disorders. Pharmaceuticals (Basel) 2020;13:E230. [PMID: 32887304 DOI: 10.3390/ph13090230] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
45 Lis M, Stańczykiewicz B, Liśkiewicz P, Misiak B. Impaired hormonal regulation of appetite in schizophrenia: A narrative review dissecting intrinsic mechanisms and the effects of antipsychotics. Psychoneuroendocrinology 2020;119:104744. [DOI: 10.1016/j.psyneuen.2020.104744] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
46 Comer AL, Carrier M, Tremblay MÈ, Cruz-Martín A. The Inflamed Brain in Schizophrenia: The Convergence of Genetic and Environmental Risk Factors That Lead to Uncontrolled Neuroinflammation. Front Cell Neurosci 2020;14:274. [PMID: 33061891 DOI: 10.3389/fncel.2020.00274] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 27.0] [Reference Citation Analysis]
47 Misiak B, Bartoli F, Carrà G, Małecka M, Samochowiec J, Jarosz K, Banik A, Stańczykiewicz B. Chemokine alterations in bipolar disorder: A systematic review and meta-analysis. Brain, Behavior, and Immunity 2020;88:870-7. [DOI: 10.1016/j.bbi.2020.04.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 13.5] [Reference Citation Analysis]
48 Pu J, Liu Y, Gui S, Tian L, Xu S, Song X, Zhong X, Chen Y, Chen X, Yu Y, Liu L, Zhang H, Wang H, Zhou C, Zhao L, Xie P. Vascular endothelial growth factor in major depressive disorder, schizophrenia, and bipolar disorder: A network meta-analysis. Psychiatry Res 2020;292:113319. [PMID: 32717712 DOI: 10.1016/j.psychres.2020.113319] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
49 Szcześniak D, Gładka A, Misiak B, Cyran A, Rymaszewska J. The SARS-CoV-2 and mental health: From biological mechanisms to social consequences. Prog Neuropsychopharmacol Biol Psychiatry 2021;104:110046. [PMID: 32730915 DOI: 10.1016/j.pnpbp.2020.110046] [Cited by in Crossref: 56] [Cited by in F6Publishing: 65] [Article Influence: 28.0] [Reference Citation Analysis]
50 Dunn GA, Loftis JM, Sullivan EL. Neuroinflammation in psychiatric disorders: An introductory primer. Pharmacol Biochem Behav 2020;196:172981. [PMID: 32621927 DOI: 10.1016/j.pbb.2020.172981] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
51 Krefft M, Frydecka D, Zalsman G, Krzystek-Korpacka M, Śmigiel R, Gębura K, Bogunia-Kubik K, Misiak B. A pro-inflammatory phenotype is associated with behavioural traits in children with Prader-Willi syndrome. Eur Child Adolesc Psychiatry 2021;30:899-908. [PMID: 32495042 DOI: 10.1007/s00787-020-01568-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
52 Macedo e Cordeiro T, Zhang X, Graubics K, Colwell R, Teixeira AL. Microbiome and Schizophrenia: Current Evidence and Future Challenges. Curr Behav Neurosci Rep 2020;7:51-61. [DOI: 10.1007/s40473-020-00206-5] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Vidal PM, Pacheco R. The Cross-Talk Between the Dopaminergic and the Immune System Involved in Schizophrenia. Front Pharmacol 2020;11:394. [PMID: 32296337 DOI: 10.3389/fphar.2020.00394] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 14.5] [Reference Citation Analysis]
54 Laurikainen H, Vuorela A, Toivonen A, Reinert-Hartwall L, Trontti K, Lindgren M, Keinänen J, Mäntylä T, Paju J, Ilonen T, Armio RL, Walta M, Tuisku J, Helin S, Marjamäki P, Hovatta I, Therman S, Vaarala O, Linnaranta O, Kieseppä T, Salokangas RKR, Honkanen J, Hietala J, Suvisaari J. Elevated serum chemokine CCL22 levels in first-episode psychosis: associations with symptoms, peripheral immune state and in vivo brain glial cell function. Transl Psychiatry 2020;10:94. [PMID: 32179746 DOI: 10.1038/s41398-020-0776-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
55 Kovács MÁ, Tényi T, Kugyelka R, Prenek L, Hau L, Magyar ÉE, Herold R, Balogh P, Simon D. Elevated Osteopontin and Interferon Gamma Serum Levels and Increased Neutrophil-to-Lymphocyte Ratio Are Associated With the Severity of Symptoms in Schizophrenia. Front Psychiatry 2019;10:996. [PMID: 32038330 DOI: 10.3389/fpsyt.2019.00996] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
56 De Picker L, Fransen E, Coppens V, Timmers M, de Boer P, Oberacher H, Fuchs D, Verkerk R, Sabbe B, Morrens M. Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations. Front Immunol 2019;10:2971. [PMID: 32010121 DOI: 10.3389/fimmu.2019.02971] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
57 Al-Hakeim HK, Almulla AF, Maes M. The Neuroimmune and Neurotoxic Fingerprint of Major Neurocognitive Psychosis or Deficit Schizophrenia: a Supervised Machine Learning Study. Neurotox Res 2020;37:753-71. [PMID: 31916129 DOI: 10.1007/s12640-019-00112-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 10.5] [Reference Citation Analysis]
58 Melbourne JK, Pang Y, Park MR, Sudhalkar N, Rosen C, Sharma RP. Treatment with the antipsychotic risperidone is associated with increased M1-like JAK-STAT1 signature gene expression in PBMCs from participants with psychosis and THP-1 monocytes and macrophages. Int Immunopharmacol 2020;79:106093. [PMID: 31863919 DOI: 10.1016/j.intimp.2019.106093] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
59 Zhao Y, Xiao W, Chen K, Zhan Q, Ye F, Tang X, Zhang X. Neurocognition and social cognition in remitted first-episode schizophrenia: correlation with VEGF serum levels. BMC Psychiatry 2019;19:403. [PMID: 31842818 DOI: 10.1186/s12888-019-2397-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
60 Momtazmanesh S, Zare-Shahabadi A, Rezaei N. Cytokine Alterations in Schizophrenia: An Updated Review. Front Psychiatry 2019;10:892. [PMID: 31908647 DOI: 10.3389/fpsyt.2019.00892] [Cited by in Crossref: 95] [Cited by in F6Publishing: 99] [Article Influence: 31.7] [Reference Citation Analysis]
61 Saoud H, Inoubli O, Ben Fredj S, Hassine M, Ben Mohamed B, Gaha L, Hadj Jrad BB. Protective Effect of the MCP-1 Gene Haplotype against Schizophrenia. Biomed Res Int 2019;2019:4042615. [PMID: 31886209 DOI: 10.1155/2019/4042615] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
62 Maj C, Tosato S, Zanardini R, Lasalvia A, Favaro A, Leuci E, De Girolamo G, Ruggeri M, Gennarelli M, Bocchio‐chiavetto L; the GET‐UP GROUP. Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first‐episode psychosis. Early Intervention in Psychiatry 2020;14:507-11. [DOI: 10.1111/eip.12906] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
63 Morris G, Puri BK, Walker AJ, Maes M, Carvalho AF, Bortolasci CC, Walder K, Berk M. Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders. Neurosci Biobehav Rev 2019;107:862-82. [PMID: 31545987 DOI: 10.1016/j.neubiorev.2019.09.025] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 14.3] [Reference Citation Analysis]
64 Wu Y, Zhang Q, Qi Y, Gao J, Li W, Lv L, Chen G, Zhang Z, Yue X, Peng S. Enzymatic activity of palmitoyl-protein thioesterase-1 in serum from schizophrenia significantly associates with schizophrenia diagnosis scales. J Cell Mol Med 2019;23:6512-8. [PMID: 31270934 DOI: 10.1111/jcmm.14496] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
65 Misiak B, Ricceri L, Sąsiadek MM. Transposable Elements and Their Epigenetic Regulation in Mental Disorders: Current Evidence in the Field. Front Genet 2019;10:580. [PMID: 31293617 DOI: 10.3389/fgene.2019.00580] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 14.0] [Reference Citation Analysis]
66 Misiak B, Bartoli F, Stramecki F, Samochowiec J, Lis M, Kasznia J, Jarosz K, Stańczykiewicz B. Appetite regulating hormones in first-episode psychosis: A systematic review and meta-analysis. Neurosci Biobehav Rev 2019;102:362-70. [PMID: 31121198 DOI: 10.1016/j.neubiorev.2019.05.018] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
67 Kroken RA, Sommer IE, Steen VM, Dieset I, Johnsen E. Constructing the Immune Signature of Schizophrenia for Clinical Use and Research; An Integrative Review Translating Descriptives Into Diagnostics. Front Psychiatry. 2018;9:753. [PMID: 30766494 DOI: 10.3389/fpsyt.2018.00753] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 13.0] [Reference Citation Analysis]
68 Drexhage HA. Editorial: Activation and de-activation of inflammatory pathways. The disequilibrium of immune-neuro-endocrine networks in psychiatric disorders. Brain Behav Immun 2019;78:5-6. [PMID: 30682504 DOI: 10.1016/j.bbi.2019.01.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
69 Misiak B, Frydecka D, Stanczykiewicz B, Samochowiec J. Editorial: Peripheral Markers of Immune Response in Major Psychiatric Disorders: Where Are We Now and Where Do We Want to Be? Front Psychiatry 2019;10:5. [PMID: 30723427 DOI: 10.3389/fpsyt.2019.00005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
70 Zhou Y, Peng W, Wang J, Zhou W, Zhou Y, Ying B. Plasma levels of IL-1Ra are associated with schizophrenia. Psychiatry Clin Neurosci 2019;73:109-15. [PMID: 30375100 DOI: 10.1111/pcn.12794] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
71 Özdin S, Böke Ö. Neutrophil/lymphocyte, platelet/lymphocyte and monocyte/lymphocyte ratios in different stages of schizophrenia. Psychiatry Res 2019;271:131-5. [PMID: 30472508 DOI: 10.1016/j.psychres.2018.11.043] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 8.3] [Reference Citation Analysis]
72 Dalton B, Campbell IC, Chung R, Breen G, Schmidt U, Himmerich H. Inflammatory Markers in Anorexia Nervosa: An Exploratory Study. Nutrients 2018;10:E1573. [PMID: 30355978 DOI: 10.3390/nu10111573] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 11.3] [Reference Citation Analysis]
73 Stapel B, Sieve I, Falk CS, Bleich S, Hilfiker-Kleiner D, Kahl KG. Second generation atypical antipsychotics olanzapine and aripiprazole reduce expression and secretion of inflammatory cytokines in human immune cells. J Psychiatr Res 2018;105:95-102. [PMID: 30216787 DOI: 10.1016/j.jpsychires.2018.08.017] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 9.0] [Reference Citation Analysis]
74 Sirivichayakul S, Kanchanatawan B, Thika S, Carvalho AF, Maes M. Eotaxin, an Endogenous Cognitive Deteriorating Chemokine (ECDC), Is a Major Contributor to Cognitive Decline in Normal People and to Executive, Memory, and Sustained Attention Deficits, Formal Thought Disorders, and Psychopathology in Schizophrenia Patients. Neurotox Res 2019;35:122-38. [PMID: 30056534 DOI: 10.1007/s12640-018-9937-8] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
75 Misiak B, Kotowicz K, Loska O, Stramecki F, Beszłej JA, Samochowiec J, Jabłoński M, Podwalski P, Waszczuk K, Wroński M, Michalczyk A, Sagan L, Piotrowski P. Decreased use of active coping styles contributes to elevated allostatic load index in first-episode psychosis. Psychoneuroendocrinology 2018;96:166-72. [PMID: 29980008 DOI: 10.1016/j.psyneuen.2018.06.021] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
76 Misiak B, Stramecki F, Stańczykiewicz B, Frydecka D, Lubeiro A. Vascular endothelial growth factor in patients with schizophrenia: A systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2018;86:24-9. [PMID: 29772306 DOI: 10.1016/j.pnpbp.2018.05.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
77 [DOI: 10.1101/393173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]